Novacyt develops, produces, and sells automated cytology solutions. The group offers liquid cytology equipment and devices, primarily for cancer detection laboratories. Net sales by source of revenue break down mainly between sales of consumables (63.8%) and sales of machinery (34.4%). Net sales are distributed geographically as follows: France (39.1%), Europe (30.8%) and other (30.1%).
Source : Cofisem